Services
Company
Insights
Contact
Leadership
Chief Executive Officer
E:
kristoffer@jarlencapital.com
P:
+46 76 193 05 02
Insight
Jul 3, 2025
The Evolving Frontier of Antibody-Drug Conjugates
Jun 22, 2025
Trends in Early Stage Licensing Deals in Oncology & Immunology
Jun 13, 2025
Crowded Targets: BioPharma’s Market Positioning Mirror